WuXi Healthcare Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
60
- Portfolio
-
17
- Exits
-
22

WuXi Healthcare Ventures General Information
Description
WuXi Healthcare Ventures was a corporate venture arm of WuXi PharmaTech and was based in Cambridge, Massachusetts with an additional office in Shanghai, China. The firm used to invest in life science, therapeutic, platform technology, and diagnostic companies, with an emphasis on China and the United States. On May 2017, the firm merged with Frontline BioVentures to form a new firm called 6 Dimensions Capital.
Contact Information
Website
www.wuxiventures.com
Investor Status
Acquired/Merged
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 55 Cambridge Parkway
- 8th Floor
- Cambridge, MA 02142
- United States
WuXi Healthcare Ventures Investments & Acquisitions (60)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
LifeMine | 07-Jan-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | |
00000000 | 17-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | |
000000000 | 28-Nov-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
00000 000000000000 | 22-Feb-2019 | 0000 00000 | 00.000 | Drug Discovery | Generating Revenue | |
000000 00000000000 | 09-May-2018 | 00000 00000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | 000000000 000 00.0 |
000000 0000000 | 02-May-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
000 00000000 | 26-Mar-2018 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 3 | 00 00 00.0 |
000000 00000000000 | 15-Mar-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00 00.0 |
DNAnexus | 02-Jan-2018 | Later Stage VC | 0000 | Discovery Tools (Healthcare) | Generating Revenue | 00 00 00.0 |
Medeor Therapeutics | 27-Nov-2017 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | 000 00 00.0 |
WuXi Healthcare Ventures Exits (22)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ivenix | 03-May-2022 | Merger/Acquisition | 00000 |
00000000 | 26-Apr-2022 | 000000000000000000 | 000.00 |
0000000 | 10-Jun-2021 | 0000000 000000 | 00000 |
0000000 | 09-Feb-2021 | 000 | 00000 |
00000000 | 01-May-2020 | 000 00 00000000 | |
0000000 0000000000 | 01-Jul-2019 | 000 00 00000000 | |
000000 00000000000 | 23-May-2019 | 000 | 0000 |
000000 00000000000 | 26-Feb-2019 | 000 | 00000 |
Twist Bioscience | 31-Oct-2018 | IPO | 0000 |
Hua Medicine | 14-Sep-2018 | IPO | 00000 |
WuXi Healthcare Ventures Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
WuXi Healthcare Ventures Investments by Industry, Year, and Region
WuXi Healthcare Ventures Team (20)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Li Zong | Executive | 0 | Cambridge, MA |
WuXi Healthcare Ventures Co-Investors (19)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 1 |
![]() |
![]() |
||
CDIB Capital Group | 0 |
![]() |
![]() |
||
Canaan Partners | 0 | 0 |
![]() |
![]() |
|
Connecticut Innovations | 0 |
![]() |
![]() |
||
Merck & Co. | 0 |
![]() |
![]() |